Skip to main content
Advertisement
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
ADVERTISEMENT
M. Shiozawa
Relative impact of T4 and N2 on the efficacy of 3 versus 6 months of adjuvant CAPOX for high-risk stage II and stage III colon cancer: ACHIEVE and ACHIEVE-2 trials
Background Results in the IDEA Collaboration have allowed clinical practice guidelines to prioritise 3-months (3m) of CAPOX for the ad...
Takeharu Yamanaka ;
Y. Maehara ;
M. Kotaka ;
M. Mori ;
D. Manaka ;
M. Shiozawa ;
Y. Sakamoto ;
Y. Munemoto ;
T. Eto ;
Kohei Shitara , MD;
A. Shiomi ;
J. Hasegawa ;
A. Makiyama ;
A. Takagane ;
Takayuki Yoshino , MD, PhD;
Eiji Oki ;
T. Kato ;
T. Mizushima ;
M. Nakamura ;
E. Sunami ;
K. Yamazaki ;
A. Ohtsu ;
06/30/2020
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Advertisement
Advertisement
Advertisement
Advertisement
Upcoming Events
December 4 – December 5
December 6 – December 7
December 9 – December 11
December 9 – December 11
December 12 – December 13
December 14 – December 15
February 2 – February 5
February 27 – March 1
March 17 – March 19
March 27 – March 30
See Full Calendar
Advertisement
Advertisement
Advertisement